How many institutions held REPL - Replimune Group, Inc. - Common stock, par value $0.001 per share in Q1 2020?

56 institutional investors reported REPL - Replimune Group, Inc. - Common stock, par value $0.001 per share for Q1 2020. Use the holders table for investor-level position and value details.

Replimune Group, Inc. - Common stock, par value $0.001 per share (REPL)

Q: What does CUSIP 76029N106 represent in this 13F holders report?

CUSIP 76029N106 is the security identifier for REPL - Replimune Group, Inc. - Common stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 76029N106

Q1 2020 13F Holders as of 31 Mar 2020

Security type / class: Equity / Common stock, par value $0.001 per share
Total 13F shares: 22,171,093
Total 13F value: $220,779,588
Share change: +150,048
SEC-reported price per share: $9.97
Number of holders: 56
Value change: -$470,574
Number of buys: 27
Number of sells: 28
Shares outstanding: 82,271,724

Security key

76029N106

Report period

Q1 2020

Institutions

Top holders

REPL full security history Ownership snapshot Full 13F holder table Replimune Group, Inc. SEC filings Replimune Group, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of REPL - Replimune Group, Inc. - Common stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Omega Fund Management, LLC

Disclosed value leader

Omega Fund Management, LLC

Comparable rows

15/15

Latest evidence

31 Dec 2019

13F Lead comparable stake: 6.5% Showing 1-6 of 15 holder rows.

Quick read

Omega Fund Management, LLC leads the comparable SEC ownership view at 6.5%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Omega Fund Management, LLC's linked filing trail.

Comparable ownership Top 5

Omega Fund Management, LLC 6.5%

Bain Capital Life Sciences Invest... 3.5%

Redmile Group, LLC 3.4%

BVF INC/IL 2.8%

BlackRock Finance, Inc. 1.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Omega Fund Management, LLC	13F Company 13F	6.5%	$76,142,000 5,323,455 shares	—	31 Dec 2019
Bain Capital Life Sciences Investors, LLC	13F Company 13F	3.5%	$40,739,000 2,838,968 shares	—	31 Dec 2019
Redmile Group, LLC	13F Company 13F	3.4%	$39,698,000 2,766,407 shares	—	31 Dec 2019
BVF INC/IL	13F Company 13F	2.8%	$33,136,000 2,309,109 shares	—	31 Dec 2019
BlackRock Finance, Inc.	13F Company 13F	1.1%	$13,398,000 933,709 shares	—	31 Dec 2019
FMR LLC	13F Company 13F	1.1%	$12,456,000 868,010 shares	—	31 Dec 2019

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

22,171,093

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2020 vs Q1 2020 Across Filers

Q1 2020 holders

Holder diff

Investor	Q1 2020 Shares	Q1 2020 Shares	Share Diff	Share Chg %	Q1 2020 value	Q1 2020 value	Value change	Value Chg %